Cutler Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,500
Closed -$52K 4466
2022
Q4
$52K Sell
26,500
-37,000
-58% -$319K ﹤0.01% 1549
2022
Q3
$96K Buy
63,500
+52,700
+488% +$302K 0.01% 1416
2022
Q2
$88K Sell
10,800
-4,100
-28% -$24.9K 0.01% 1522
2022
Q1
$57K Sell
14,900
-100
-0.7% -$1.15K ﹤0.01% 2137
2021
Q4
$38K Buy
15,000
+200
+1% +$4.83K ﹤0.01% 2615
2021
Q3
$53K Sell
14,800
-25,400
-63% -$753K ﹤0.01% 2466
2021
Q2
$66K Sell
40,200
-4,400
-10% -$128K ﹤0.01% 2245
2021
Q1
$203K Buy
44,600
+21,000
+89% +$735K 0.01% 1264
2020
Q4
$18K Buy
+23,600
New +$401K ﹤0.01% 2757
2017
Q3
Sell
-6,300
Closed -$9K 6475
2017
Q2
$9K Sell
6,300
-100
-2% -$403 ﹤0.01% 4274
2017
Q1
$4K Sell
6,400
-1,700
-21% -$8.32K ﹤0.01% 4922
2016
Q4
$42K Sell
8,100
-26,600
-77% -$193K ﹤0.01% 2723
2016
Q3
$49K Buy
34,700
+7,500
+28% +$62.7K ﹤0.01% 2496
2016
Q2
$103K Buy
27,200
+9,000
+49% +$82.2K 0.01% 1667
2016
Q1
$36K Buy
+18,200
New +$179K ﹤0.01% 2672

Other funds holding PACB